Ovation Science Inc. (CSE: OVAT | OTC: OVATF) has announced the death of Doreen McMorran, a long-serving member of its Board of Directors and its Chief Financial Officer. McMorran joined the company's leadership team in 2017 and held multiple senior roles over nearly a decade of service. The announcement, dated September 17, 2026, reflects a significant loss for the Vancouver-based cannabinoid research and development company and its leadership structure.

Key Points

  • Ovation Science Inc. (CSE: OVAT | OTC: OVATF) announced the passing of board member and CFO Doreen McMorran
  • McMorran served as a Director and Vice-President since 2017, Chief Operating Officer since 2018, and Chief Financial Officer since 2023
  • CEO Terry Howlett described her as instrumental in shaping Ovation from its earliest days
  • Investors will be watching for any company announcements regarding succession to her CFO and COO roles

McMorran's Tenure and Contributions to Ovation Science

Doreen McMorran joined Ovation Science as a Director and Vice-President in 2017, taking on the role of Chief Operating Officer in 2018 and Chief Financial Officer in 2023. The release states she held all three roles simultaneously at the time of her passing, reflecting the breadth of her responsibilities within the organisation. CEO Terry Howlett described her dedication, vision, and strategic guidance as instrumental in shaping Ovation from its earliest days, and acknowledged her as both a valued colleague and a friend to the broader team.

CEO Statement and Board Response to the Loss

In a statement included in the announcement, CEO Terry Howlett expressed condolences on behalf of the entire team and Board of Directors, extending sympathy to McMorran's family and loved ones. "Her dedication, vision, and strategic guidance were instrumental in shaping Ovation from its earliest days," the release quotes Howlett as saying. The announcement was made on behalf of the Board of Directors and signed by Howlett. The company did not disclose any interim appointments or succession arrangements in this announcement.

About Ovation Science and Its Invisicare® Technology

Ovation Science is a research and development company focused on topical and transdermal cannabinoid products, distributed under its own brands and out-licensed to partners. Its products are powered by its patented Invisicare® skin delivery technology, which enhances ingredient delivery to and through the skin. The company earns revenues from royalties on licensee sales, Invisicare® sales, and its own product lines. Ovation maintains offices in Vancouver, Canada and Las Vegas, USA, and lists on both the CSE and OTC Markets.